Sarepta (SRPT) Trades Higher on Eteplirsen Phase II Update, Analyst Comments
Go back to Sarepta (SRPT) Trades Higher on Eteplirsen Phase II Update, Analyst Comments| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 51.96 -0.92 (1.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.88 | 52 Week High | $45.58 | |||
| Open | $52.57 | 52 Week Low | $37.82 | |||
| Day High | $52.63 | P/E | N/A | |||
| Day Low | $51.86 | EPS | $0.00 | |||
| Volume | 3,598,425 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 19.22 -0.51 (2.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.73 | 52 Week High | $63.73 | |||
| Open | $19.42 | 52 Week Low | $8.00 | |||
| Day High | $19.95 | P/E | N/A | |||
| Day Low | $18.59 | EPS | $-5.69 | |||
| Volume | 2,911,296 | |||||
